Follow-up of Stage B and C colorectal cancer in the United States and France

Seminars in Oncology

Volumn 28, Issue 1 SUPPL. 1, 2001, Pages 45-49

  O'Dwyer, Peter J ^a,c   Stevenson, James P ^a,b   Haller, Daniel G ^a,b   Rotman, Nelly ^a,b   Giantonio, Bruce J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IRINOTECAN; OXALIPLATIN;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; FOLLOW UP; FRANCE; HEALTH ECONOMICS; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; UNITED STATES;

EID: 0035101694     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.19729     Document Type: Conference Paper

References (33)

1. Temporal patterns in colorectal cancer incidence, survival and mortality from 1950 through 1990
2. Systemic treatment of colorectal cancer
3. Cancer of the colon
4. Chemotherapy for colorectal cancer
5. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
6. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01
7. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment
8. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie
9. Surgery for pulmonary metastases from colorectal carcinoma
10. Chemotherapy of advanced colorectal cancer
11. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
12. Weekly irinotecan, leucovorin and fluorouracil is superior to daily × 5 LV/FU in patients with previously untreated metastatic colorectal cancer
13. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
14. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
15. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial
16. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
17. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver
18. Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection
19. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer
20. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology
21. Surveillance strategies after resection of carcinoma of the colon and rectum
22. Current follow-up strategies after resection of colon cancer
23. Follow-up of colorectal cancer-A meta-analysis
24. Follow-up of patients with colorectal cancer: A meta-analysis
25. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiological test results
26. Post-operative follow-up of patients with cancer of the colon
27. Follow-up of patients with colorectal cancer
28. Colorectal cancer: Principles of post-operative follow-up
29. Surveillance for second primary colon cancers after adjuvant chemotherapy: Analysis of INT-0089
30. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup
31. Current perspectives on the follow up of surgically resected colorectal cancer
32. Can the prognosis of patients treated surgically in cancer of the rectum or colon be improved by follow-up? A prospective study of 909 patients
33. Prevention, diagnosis and treatment of colon cancer